Archimedes Pharma Overview
- Latest Deal Type
- Financing Rounds
Archimedes Pharma General Information
Producer of pharmaceuticals for the European markets. The company was created to form a pan-European specialty pharmaceutical company through a roll-up of European pharmaceutical businesses and offers products that treat high-grade glioma, cancer pain, alcohol misuse, thromboprophylaxis and moderate to severe pain.
- 250 South Oak Way Green Park
- Reading RG2 6UG
- England, United Kingdom
Want detailed data on 3M+ companies?
What you see here scratches the surfaceRequest a free trial
Want to dig into this profile?
We’ll help you find what you needLearn more
Archimedes Pharma Valuation & Funding
Archimedes Pharma Signals
Archimedes Pharma Former Investors
|Investor Name||Investor Type||Holding||Investor Since||Participating Rounds||Contact Info|
Archimedes Pharma Investments (2)
|Company Name||Deal Date||Deal Type||Deal Size||Industry||Lead Partner|
|0000000000 00||06-Nov-2006||0000000000||Pharmaceuticals||0000000 0|
|West Pharmaceutical Services (Drug Delivery Business)||08-Feb-2005||Buyout/LBO||000.00||Drug Delivery||0000000 0|